Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis
Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Unknown status
CT.gov ID
NCT01991925
Collaborator
(none)
130
1
Study Details
Study Description
Brief Summary
Patients with hereditary haemochromatosis will be interviewed/questioned about their Quality of life and the delivered quality of care in the hospital.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
130 participants
Time Perspective:
Prospective
Official Title:
Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis
Study Start Date
:
Jan 1, 2014
Anticipated Primary Completion Date
:
Mar 1, 2014
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| quality of life, quality of care
|
Other: Interviews, questionaires, RAND-modified delphi method round
phase 1: RAND-modified delphi method round with experts in hereditary haemochromatosis phase 2: patient interviews, questionaires and focusgroup interviews
|
Outcome Measures
Primary Outcome Measures
- evaluation of quality of life [after 3 months of treatment]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
phase 1: experts in the field of haemochromatosis (hepatologists, hematologists, endocrinologists, general practitioner, nurses, ...)
-
phase 2: patients with hereditary haemochromatosis, treatment with phlebotomy since 3 months, Dutch/English speaking
Exclusion Criteria:
-
patients with secundary iron overload
-
phlebotomy treatment less than 3 months
-
language: no Dutch or English
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | UZ Leuven | Leuven | Vlaams-brabant | Belgium | 3000 |
Sponsors and Collaborators
- Universitaire Ziekenhuizen Leuven
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Annick Vanclooster,
Nurse,
Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT01991925
Other Study ID Numbers:
- UZL-INT-01
First Posted:
Nov 25, 2013
Last Update Posted:
Nov 25, 2013
Last Verified:
Nov 1, 2013